PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-200.00%
Negative net income growth while CRK stands at 18.82%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
9.09%
Some D&A expansion while CRK is negative at -146.12%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-200.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
533.33%
SBC growth while CRK is negative at -5.81%. John Neff would see competitor possibly controlling share issuance more tightly.
-1225.00%
Negative yoy working capital usage while CRK is 377.18%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-7000.00%
Both yoy AR lines negative, with CRK at -249.28%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
700.00%
Lower 'other working capital' growth vs. CRK's 8690.89%. David Dodd would see fewer unexpected short-term demands on cash.
211.11%
Well above CRK's 47.58%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
24.67%
Operating cash flow growth below 50% of CRK's 203.59%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-17.13%
Negative yoy CapEx while CRK is 5.08%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
170.59%
Acquisition growth of 170.59% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
520.00%
Growth of 520.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
13.95%
Lower net investing outflow yoy vs. CRK's 223.46%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-4.55%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
19.82%
Buyback growth of 19.82% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.